You just read:

Clementia Advances Phase 2 Clinical Trial of Palovarotene in Fibrodysplasia Ossificans Progressiva Based on Recommendations from Data Monitoring Committee (DMC)

News provided by

Clementia Pharmaceuticals, Inc.

02 Apr, 2015, 13:00 BST